| Literature DB >> 35276969 |
Ting Tian1, Yuanyuan Wang1,2, Wei Xie1, Jingxian Zhang1, Yunlong Ni1, Xianzhen Peng3, Guiju Sun2, Yue Dai1, Yonglin Zhou1.
Abstract
Vitamin A, a fat-soluble essential vitamin, is implicated in a large range of physiological processes. Up to now, the associations between vitamin A and metabolic syndrome (MetS) or other metabolic risk factors are controversial in children and adolescents. Thus, we aimed to dig into the relationship of vitamin A with MetS and many other metabolic risk factors. This was a cross-sectional study derived from the China National Nutrition and Health Surveillance of Children and Lactating Mothers. A total of 3025 school-aged (7-17 years) children and adolescents were selected by applying multistage stratified cluster random sampling methods in the Jiangsu Province of eastern China. Through enquiry survey, anthropometric measurement and laboratory examination, relevant information and blood biochemical indexes of the participants were collected in this study. MetS was identified according to the modified criteria of the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III). Multivariate logistic analysis and the generalized additive model (GAM) were used to analyze the relationship between vitamin A and various metabolic risk factors. The overweight, obesity and MetS prevalence of children and adolescents in this study was 14.0%, 11.9% and 5.1%, respectively. The risk of prevalent MetS, general obesity, high low-density lipoprotein (LDL), high total cholesterol (TC) and hyperuricemia increased with vitamin A in a dose-dependent way. Logistic regression analysis showed that serum vitamin A Z scores were positively associated with MetS and central obesity, elevated blood pressure (BP) and elevated triglyceride (TG). Sex stratification analysis showed that both in male and female participants, the risk of prevalent MetS, general obesity, high LDL, high TC and hyperuricemia still increased with vitamin A levels. MetS was at a high prevalence level in children and adolescents in Jiangsu that were 7-17 years old. Vitamin A was positively associated with obesity, MetS, dyslipidemia and hyperuricemia. More public health measures and new visions should focus on the effects of retinol on children and adolescents.Entities:
Keywords: children and adolescents; metabolic risk factors; metabolic syndrome; vitamin A
Mesh:
Substances:
Year: 2022 PMID: 35276969 PMCID: PMC8839095 DOI: 10.3390/nu14030610
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Basic information of male and female participants.
| Variables | Serum Vitamin A Levels | |||||
|---|---|---|---|---|---|---|
| Q1 ( | Q2 ( | Q3 ( | Q4 ( | |||
| Age, years | 10.2 ± 2.7 | 10.8 ± 2.8 | 11.8 ± 3.0 | 12.8 ± 2.7 | <0.001 | <0.001 |
| Residence | <0.001 | <0.001 | ||||
| Urban | 596 (78.8) | 638 (84.3) | 655 (86.0) | 642 (85.6) | ||
| Rural | 160 (21.2) | 119 (15.7) | 107 (14.0) | 108 (14.4) | ||
| Physical activity | 0.114 | 0.151 | ||||
| Low | 460 (60.8) | 482 (63.7) | 442 (58.0) | 442 (58.9) | ||
| High | 296 (39.2) | 275 (36.3) | 320 (42.0) | 308 (41.1) | ||
| Screen time | 0.708 | 0.700 | ||||
| Low | 657 (86.9) | 672 (88.8) | 673 (88.3) | 658 (87.7) | ||
| High | 99 (13.1) | 85 (11.2) | 89 (11.7) | 92 (12.3) | ||
| Anthropometrics | ||||||
| Height (cm) | 141.8 (132.3, 155.2) | 146.6 (135.1, 160.2) | 155.6 (141.9, 164.4) | 160.0 (150.9, 168.0) | <0.001 | <0.001 |
| Weight (kg) | 34.5 (27.4, 46.0) | 39.1 (29.8, 50.6) | 47.2 (34.5, 57.2) | 52.6 (42.2, 63.1) | <0.001 | <0.001 |
| WC (cm) | 59.9 (54.3, 65.7) | 62.1 (56.4, 69.1) | 65.7 (59.0, 73.0) | 69.3 (62.9, 77.8) | <0.001 | <0.001 |
| BMI (kg/m2) | 16.8 (15.4, 19.2) | 17.8 (15.8, 20.4) | 19.1 (16.7, 22.0) | 20.5 (17.9, 23.3) | <0.001 | <0.001 |
| SBP (mmHg) | 111.7 (104.3, 119.3) | 114.0 (106.0, 122.3) | 115.7 (107.7, 123.7) | 117.3 (110.3, 125.7) | <0.001 | <0.001 |
| DBP (mmHg) | 66.7 (61.3, 73.0) | 67.0 (61.7, 73.3) | 67.3 (62.3, 72.3) | 69.0 (64.7, 74.0) | <0.001 | <0.001 |
| Biochemistry | ||||||
| FBG (mmol/L) | 5.2 (4.9, 5.5) | 5.2 (4.9, 5.5) | 5.3 (5.0, 5.6) | 5.3 (5.0, 5.6) | 0.010 | 0.036 |
| TG (mmol/L) | 0.7 (0.6, 0.9) | 0.8 (0.6, 1.0) | 0.8 (0.6, 1.1) | 1.0 (0.7, 1.3) | <0.001 | <0.001 |
| TC (mmol/L) | 3.9 (3.5, 4.3) | 4.1 (3.7, 4.6) | 4.0 (3.6, 4.5) | 4.1 (3.7, 4.7) | <0.001 | <0.001 |
| LDL (mmol/L) | 2.1 (1.8, 2.4) | 2.2 (1.9, 2.6) | 2.2 (1.8. 2.6) | 2.3 (1.9, 2.7) | <0.001 | <0.001 |
| HDL (mmol/L) | 1.6 (1.4, 1.9) | 1.6 (1.4, 1.9) | 1.6 (1.4, 1.9) | 1.5 (1.3, 1.8) | <0.001 | <0.001 |
| Serum Uric acid (μmol/L) | 270.0 (237.0, 314.8) | 296.0 (252.0) | 322.0 (278.0, 375.0) | 358.0 (300.8, 419.3) | <0.001 | <0.001 |
WC: waist circumference, BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, FBG: fast blood glucose, TG: triglyceride, TC: total cholesterol, LDL: low-density lipoprotein, HDL: high-density lipoprotein.
Prevalence of metabolic disease conditions across serum vitamin A quartiles in children and adolescents.
| Metabolic Condition | Serum Vitamin A Levels | |||||
|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | |||
| Weight groups | <0.001 | <0.001 | ||||
| Others | 627 (82.9) | 587 (77.6) | 552 (72.4) | 474 (63.4) | ||
| Overweight | 71 (9.4) | 103 (13.6) | 114 (15.0) | 134 (17.9) | ||
| Obesity | 58 (7.7) | 66 (8.7) | 96 (12.6) | 140 (18.7) | ||
| Metabolic syndrome | <0.001 | <0.001 | ||||
| No | 740 (97.9) | 733 (96.8) | 726 (95.3) | 671 (89.5) | ||
| Yes | 16 (2.1) | 24 (3.2) | 36 (4.7) | 79 (10.5) | ||
| Obesity phenotype | <0.001 | <0.001 | ||||
| MHNO | 691 (91.4) | 679 (89.7) | 651 (85.4) | 586 (78.1) | ||
| MHO | 49 (6.5) | 54 (7.1) | 75 (9.8) | 85 (11.3) | ||
| MNHNO | 7 (0.9) | 12 (1.6) | 15 (2.0) | 24 (3.2) | ||
| MNHO | 9 (1.2) | 12 (1.6) | 21 (2.8) | 55 (7.3) | ||
MHNO: metabolically healthy non-obese, MHO: obese but absence of MetS, MNHNO: non-obese subjects with MetS, MNHO: obese subjects with MetS.
Association of metabolic risk factors and serum vitamin A in logistic regression analysis in 7–17 years males and females.
| Metabolic Risk Factors | Vitamin A Quantiles | ||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | ||
| Metabolic syndrome | |||||
| Model 1 | 1 (reference) | 1.514 (0.798–2.874) | 2.293 (1.261–4.169) | 5.445 (3.150–9.413) | <0.001 |
| Model 2 | 1 (reference) | 1.479 (0.777–2.813) | 2.244 (1.221–4.123) | 5.257 (2.968–9.310) | <0.001 |
| Central obesity | |||||
| Model 1 | 1 (reference) | 1.404 (1.037–1.899) | 1.961 (1.469–2.617) | 3.299 (2.503–4.349) | <0.001 |
| Model 2 | 1 (reference) | 1.444 (1.063–1.962) | 2.257 (1.674–3.042) | 4.135 (3.073–5.564) | <0.001 |
| Elevated blood pressure | |||||
| Model 1 | 1 (reference) | 1.065 (0.868–1.307) | 1.014 (0.826–1.245) | 1.059 (0.863–1.300) | 0.260 |
| Model 2 | 1 (reference) | 1.150 (0.934–1.416) | 1.224 (0.989–1.515) | 1.420 (1.114–1.770) | <0.001 |
| Elevated FBG | |||||
| Model 1 | 1 (reference) | 0.916 (0.515–1.629) | 1.282 (0.752–2.184) | 1.092 (0.628–1.900) | 0.733 |
| Model 2 | 1 (reference) | 0.835 (0.467–1.491) | 1.075 (0.619–1.868) | 0.820 (0.456–1.475) | 0.386 |
| Low HDL | |||||
| Model 1 | 1 (reference) | 0.637 (0.384–1.054) | 0.632 (0.382–1.047) | 0.798 (0.496–1.284) | 0.516 |
| Model 2 | 1 (reference) | 0.607 (0.364–1.013) | 0.549 (0.325–0.927) | 0.611 (0.366–1.018) | 0.121 |
| High TG | |||||
| Model 1 | 1 (reference) | 1.469 (1.030–2.096) | 2.003 (1.428–2.811) | 4.706 (3.439–6.441) | <0.001 |
| Model 2 | 1 (reference) | 1.515 (1.060–2.166) | 2.072 (1.466–2.930) | 4.903 (3.524–6.820) | <0.001 |
| General Obesity | |||||
| Model 1 | 1 (reference) | 1.149 (0.795–1.661) | 1.735 (1.231–2.444) | 2.762 (1.996–3.822) | <0.001 |
| Model 2 | 1 (reference) | 1.227 (0.843–1.784) | 2.277 (1.592–3.256) | 4.101(2.877–5.845) | <0.001 |
| High LDL | |||||
| Model 1 | 1 (reference) | 1.837 (1.054–3.204) | 1.825(1.046–3.182) | 2.798 (1.656–4.729) | <0.001 |
| Model 2 | 1 (reference) | 1.940 (1.109–3.394) | 2.156(1.223–3.799) | 3.779 (2.177–6.559) | <0.001 |
| High TC | |||||
| Model 1 | 1 (reference) | 1.868 (1.190–2.933) | 1.963 (1.255–3.069) | 2.753 (1.794–4.226) | <0.001 |
| Model 2 | 1 (reference) | 1.910 (1.213–3.008) | 2.125 (1.347–3.355) | 3.318 (2.115–5.205) | <0.001 |
| Hyperuricemia | |||||
| Model 1 | 1 (reference) | 1.750 (1.330–2.304) | 3.338 (2.575–4.326) | 6.816 (5.280–8.797) | <0.001 |
| Model 2 | 1 (reference) | 1.565 (1.167–2.099) | 2.641 (1.988–3.507) | 4.709 (3.552–6.242) | <0.001 |
Model 1 not adjusted; Model 2 adjusted by age, gender, area, screen time, physical activity time. FBG: fast blood glucose, HDL: high-density lipoprotein, TG: triglyceride, LDL: low-density lipoprotein, TC: total cholesterol.
Figure 1Dose-response curves with 95% confidence interval (CI) were modelled for the associations of serum vitamin A and numerous metabolic risk factors by the generalized additive model (GAM). (A). the association between vitamin A concentrations and WC. (B). the association between vitamin A concentrations and BMI. (C). the association between vitamin A concentrations and TG. (D). the association between vitamin A concentrations and TC. (E). the association between vitamin A concentrations and LDL. (F). the association between vitamin A concentrations and SUA. Abbreviations: waist circumference (WC), body mass index (BMI), triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL), serum uric acid (SUA).
Figure 2The forest plot of logistic regression analysis results for the associations of serum vitamin A Z scores with MetS and its components. Vitamin A was converted to a z-score by this equation: (Vitamin A − Vitamin Amean)/Vitamin ASD.